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Keratin 1/10
Histone 1bThe number of ultraviolet (UV) radiation-induced skin diseases such as melanomas is on the rise. The altered
behavior of keratinocytes is often coupled with signaling events in which Ser/Thr speciﬁc protein kinases and
phosphatases regulate various cellular functions. In the present study the role of protein phosphatase-1 (PP1)
was investigated in the response of human keratinocyte (HaCaT) cells and mouse skin to UV radiation. PP1
catalytic subunit (PP1c) isoforms, PP1cα/γ and PP1cδ, are all localized to the cytoskeleton and cytosol of
keratinocytes, but PP1cδ was found to be dominant over PP1α/γ in the nucleus. PP1c-silencing in HaCaT cells
decreased the phosphatase activity and suppressed the viability of the cells. Exposure to a 10 J/cm2 UVA dose
induced HaCaT cell death and resulted in a 30% decrease of phosphatase activity. PP1c-silencing and UVA irradi-
ation altered the gene expression proﬁle of HaCaT cells and suggested that the expression of 19 genes was reg-
ulated by the combined treatments with many of these genes being involved in malignant transformation.
Microarray analysis detected altered expression levels of genes coding for melanoma-associated proteins such
as keratin 1/10, calcium binding protein S100A8 and histone 1b. Treatment of Balb/c mice with the PP1-
speciﬁc inhibitor tautomycin (TM) exhibited increased levels of keratin 1/10 and S100A8, and a decreased
level of histone 1b proteins following UVA irradiation. Moreover, TM treatment increased pigmentation of the
skin which was even more apparent when TM was followed by UVA irradiation. Our data identify PP1 as a
regulator of the normal homeostasis of keratinocytes and the UV-response.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
It is well established that many environmental and genetic factors
contribute to the development of skin cancer, however, among these
factors one of the most important causative factor is chronic exposure
of the skin to solar UV radiation [1]. The solar UV spectrum includes
UVA (320–400 nm), which is 90–95% of the total solar UV radiation
and considered to be the “aging ray” causing benign tumor formation
as well as malignant cancers [2]. UVB (280–320 nm) is thought to be
responsible for a wide range of skin diseases such as non-melanomacatalytic subunit; PP2A, protein
omycin; OA, okadaic acid; PBS,
; UV, ultraviolet; KRT, keratin;
ermal keratinocyte; I-2, inhibi-
hemistry, Faculty of Medicine,
ér 1, Hungary. Tel.: +36 52and melanoma skin cancers. UVB acts as a tumor initiator and co-
carcinogen by triggering DNA damage, immunosuppression and oxida-
tive stress [3]. UVC radiation (200–280 nm) has no signiﬁcant effect on
biological systems since it is largely absorbed by stratospheric ozone [4].
UV irradiation initiates the transcription of numerous genes
encoding multiple proteins, which play a role in skin cell apoptosis,
malignant transformation, aging of the cells aswell as collagen degrada-
tion [5]. Thus, UV light can be absorbed by several target chromophores
in the skin such as nucleic acids, NADPH and heme-containing enzymes
relevant for cellular signaling. DNA can absorb only UVB light, while it is
affected by UVA light in an indirect manner whereby UVA-irradiated
cells overproduce reactive oxygen species (ROS) resulting in ROS-
induced DNA damage [6]. UV radiation can cause severe damage on
many tissue components including proteins, membrane lipids and
nucleic acids. It has also been recognized as amajor regulator of cellular
processes mediated by growth factors and cytokine-mediated signal
transduction pathways. Its effects might include inﬂuence on phospho-
lipids, protein kinases (MAP kinases, tyrosine kinases, Ser/Thr speciﬁc
kinases) and protein phosphatases, leading to pathological (abnormal)
gene expression [7]. The combined action of these pathways eventually
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ciated that the effects of UV light on certain signaling pathways are
wavelength-speciﬁc [8,9] and are related mostly to the activation of
MAPK, AKT/mTOR, AMPK and p53 signaling by protein phosphorylation
[5]. The UV-induced changes in the phosphorylation of cellular proteins
by protein kinases are relatively well established, while little is known
about the regulatory role of the protein phosphatases which ensure
the reversibility of these phosphorylation processes.
In the human genome almost 40 genes encode for phospho-Ser/Thr
speciﬁc protein phosphatases (PP) [10] which are termed as PP1 to PP7
[11]. Among these types PP1 and PP2A are assumed to catalyze the
dephosphorylation of over 90% of all eukaryotic phosphoproteins [12].
In fact, PP1 and PP2A are two of the most abundant enzymes and they
are highly characterized in many cell types including skin cells [13].
Mammalian genomes contain three different genes that encode four
distinct catalytic subunits termed PP1α, PP1β/δ and PP1γ1 [14], and a
splice variant PP1γ2 [15] expressed ubiquitously except for the latter
one. The substrate speciﬁcity and distinct subcellular localization of
PP1 is regulated by various targeting subunits [16], and several of
them (PNUTS, pRb, Repo-Man, GADD34, etc.) have recently been identi-
ﬁed as regulators of UV-mediated pathways such as DNA damage, cell
cycle, centrosome separation and apoptosis [17]. Hence, it is important
to elucidate the mechanisms by which PP1 enzymes may regulate the
UV radiation-induced pathologies and the underlying cellular events.
In this study, we report that PP1 enzymes play an important role in
the maintenance of the homeostasis in human keratinocytes as well as
in mouse skin. We also suggest that pathological processes could result
from the selective regulation of PP1 enzyme activity by UVA irradiation.
2. Material and methods
2.1. Chemicals and antibodies
All chemicals were obtained from Sigma-Aldrich unless otherwise
indicated. Antibodies were as follows: anti-KRT 1 (against middle re-
gion) and anti-KRT 10 (against N-terminal region) from Aviva System
Biotechnology; afﬁnity isolated anti-S100A8, horseradish-peroxidase
(HRP) conjugated anti-rabbit IgG and anti-actin from Sigma-Aldrich;
monoclonal anti-histone H1 (AE-4), anti-α-tubulin, anti-GAPDH and
monoclonal anti-PP1 (E9) antibodies from Santa Cruz Biotechnology;
afﬁnity isolated anti-PP1cδ fromUpstateMillipore; anti-PP2Ac antibody
from BD Biosciences; anti-PARP, anti-cleaved PARP antibodies and
HRP-linked anti-mouse IgG from Cell Signaling Technology; Alexa
Fluor 488- and Alexa Fluor 546-conjugated anti-mouse and anti-rabbit
IgG from Molecular Probes.
2.2. Cell culture, gene silencing and UV radiation
Human keratinocyte (HaCaT) cells (300493, CLS Cell Lines Service
GmbH, Germany) were grown in high glucose DMEM supplemented
with 10% heat-inactivated FBS and 2 mM L-glutamine in humidiﬁed
5% CO2 atmosphere at 37 °C. All materials used for cell culturewere pur-
chased from PAA Laboratories, Austria. Normal human epidermal
keratinocyte (NHEK) cultures were generously donated by Dr. Tamas
Bíró (University of Debrecen, Department of Physiology) and main-
tained in Epilife medium complemented with Human Keratinocyte
Growth Supplement (HKGS), 100 μg/ml streptomycin, 100 IU/ml
penicillin and 50 ng/ml amphotericin B (all from Life Technologies)
and were cultured on 1% collagen-coated plates. Double-stranded
siRNA (100 nM) (Santa Cruz Biotechnology) was used to knock down
the protein levels of endogenous PP1 isoforms (α, β/δ and γ) and a
non-target sequence (Thermo Scientiﬁc Inc.) with the G–C content of
the siPP1 sequence was applied in control experiments according to
the manufacturer's protocol. 100 nM siRNAs were transfected into
HaCaT cells using a Dharmafect 2 transfection reagent (Thermo Scientiﬁc
Inc.) in serum-free medium. After 30 min, the medium was completedwith 10% FBS and cells were incubated for 48 h. Then prior to UV
irradiation, cells were kept in serum-free medium for 16 h in each case.
UV irradiation was carried out using a Bio-Sun UV irradiation system
(Vilbert Lourmat, France). After 24 hour incubation cells were either
lysed for immunoblotting andmicroarray analysis andwere ﬁxed for im-
munoﬂuorescent staining or utilized for MTT assay. 1 μM of tautomycin
was applied for 1 h before UV irradiation and cells were treated as it
was described before. In the case of protein phosphatase activity mea-
surement cells were lysed and assayed right after TM treatment or UV
irradiation.
2.3. Cell disruption and protein measurement
Treated cells were collected and washed by ice-cold Dulbecco's PBS
without calcium, magnesium and phenol red (pH: 7.2; 2.7 mmol/l KCl,
1.5 mmol/l KH2PO4, 136.9 mmol/l NaCl, 8.9 mmol/l Na2HPO4·7H2O)
and lysed in modiﬁed RIPA buffer (25 mM Tris–HCl, pH 7.6, 150 mM
NaCl, 1% (v/v) Nonidet P-40, 0.1% (w/v) SDS, 1mMDTT) containingpro-
tease inhibitor cocktail Complete Mini (Roche Diagnostics GmbH,
Switzerland) followed by 3 × 15 s sonication on ice. After centrifugation
(16,000 ×g for 15min at 4 °C), protein concentration of the supernatant
was determined by the BCA method (BCA protein assay kit, Pierce
Biotechnology, USA) using an ELISA reader (Labsystem Multiscan MS)
at 540 nmwith BSA as a standard as described before [18]. Alternatively
subcellular factions of HaCaT cells were prepared as described before
[19].
2.4. MTT assay
The assaywas used to determine the viability of HaCaT cells. AnMTT
reagent was prepared by adding 5 mg of 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide to 1 ml PBS. The cell culture medium
was replaced and 20 μl of MTT was added to each well of the 96-well
plate (200 μl). The plates were incubated for 1–3 h at 37 °C in 5% CO2
atmosphere. The medium was removed and 100 μl DMSO was added
to the wells for dissolving the formazan crystals in the cells and the
absorbance at 540 nm was recorded.
2.5. Immunoblotting
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and immunoblotting were carried out as detailed before [19].
After blocking in 5% (w/v) non-fat dry milk, the membranes were
washed with PBS containing 0.1% Tween 20 (PBST) and incubated
with primary antibodies overnight at 4 °C, followed by application
of the HRP-conjugated secondary antibodies. To determine the
changes in the protein expression levels of histone 1b, keratin 1
and 10 as well as S100A8, speciﬁc antibodies were applied to detect
changes. Immunoreactions were detected by enhanced chemilumi-
nescence (ECL). Densitometry of the proteins of interest were per-
formed by Image J. 1.46 and normalized to tubulin internal control
(run on the same gel) and plotted as relative numbers (in %). To assess
the extent of apoptosis of NHEK and HaCaT cells after TM treatment
and UVA irradiation Western blot analysis was carried out on 30 μg of
cell lysates using anti-PARP (1:500) and anti-cleaved PARP (1:500),
antibodies.
2.6. Immunoﬂuorescence microscopy
Paraformaldehyde (4%)was used forﬁxation (10min) of HaCaT cells
followed by three washes with ice-cold PBS. Cells were permeabilized
with 0.02% (v/v) Triton X-100 dissolved in PBS for 10 min at room tem-
perature and washed three times with PBS. After blocking in 1% (w/v)
sterile BSA in PBS for 1 h, coverslips were incubated with anti-PP1c
(E9), anti-PP1cδ, anti-PP2A and anti-KRT1 (all in 1:100 dilution) prima-
ry antibodies overnight at 4 °C. After extensive washing with PBS,
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conjugated anti-rabbit IgG and Alexa 596-conjugated anti-mouse
IgG). Nuclear counterstaining was performed by 1 μg/ml DAPI
(4′,6-diamidino-2-phenylindole). Coverslips were washed three
times for 10 min in PBS and were mounted in ProLong Gold Antifade
medium. Cells were observed with a 60× objective on a Zeiss Axioskop
HBO50/AC microscope. Images were processed using PhotoShop
Imaging software.
2.7. Immunohistochemistry
One-half of the skin samples were immediately ﬁxed in 10% neutral-
buffered formalin and embedded in parafﬁn. Sections (4 μm) were cut
and mounted on glass slides (Superfrost/plus; A. Daigger & Company,
Inc., Vernon Hills, IL), deparafﬁnized by xylene, dehydrated by graded
ethanol and processed for hematoxylin and eosin (H&E) staining as de-
scribed before [20]. Immunohistochemical staining of keratin 1, -10,
S100A8 and histone 1b was also carried out incubating the sections
with primary antibodies overnight at 4 °C. Sections were washed and
incubated with anti-mouse or anti-rabbit HRP conjugated secondary
antibody and immunosignals were developed by nickel/cobalt en-
hanced 3,3′-diaminobenzidine (DAB) chromogen substrate without
any counterstaining. The sections were cleared with xylene before
ﬁnally being mounted. The other half of the samples was used for
Western blot analysis.
2.8. Protein phosphatase assay
The PP1 and PP2A activities of the HaCaT cell lysate and subcellular
fractionswere assayedwith a 1 μM32P-labeled 20 kDa light chain of tur-
key gizzard myosin (32P-MLC20) at 30 °C in 20 mM Tris–HCl (pH 7.4)
and 0.1% 2-mercaptoethanol. To differentiate between PP1 and PP2A
protein phosphatase activities by 5 nM okadaic acid (OA) subcellular
fractions of the HaCaT cell lysate were diluted to 300-fold. To determine
the phosphatase type speciﬁcity of inhibition by TM treatment and
UVA irradiation cell lysates (1.5–2 mg/ml) were assayed in 30-fold
ﬁnal dilution in the absence or presence of 2 μM inhibitor-2 (I-2). The
reaction was initiated by the addition of the substrate. After a 5 minute
incubation the reaction was terminated by the addition of 200 μl 10%
TCA and 200 μl 6 mg/ml BSA. The precipitated proteins were collected
by centrifugation and the released 32Pi was determined from the super-
natant (380 μl) in a scintillation counter. Valueswere expressed as nmol
Pi released per minute for the subcellular fractions, while in the case of
TM treatment and UVA irradiation the phosphatase activity of the
untreated cells was taken as 100%.Table 1
Effect of UV radiation on the gene expression of PP1-silenced HaCaT cells.
Gene symbol Gene description
SPRR1A Small proline-rich protein 1A
SYT14 Synaptotagmin XIV
S100A8 S100 calcium binding protein A8
PPP1CA (PP1cα) Protein phosphatase 1, catalytic subunit, alpha isoform
PPP1CB (PP1cβ/δ) Protein phosphatase 1, catalytic subunit, beta isoform
PPP1CC (PP1cγ) Protein phosphatase 1, catalytic subunit, gamma isofo
KRT1 Keratin 1
KRT10 Keratin 10
CSTA Cystatin A (steﬁn A)
SLC10A5 Solute carrier family 10
CALB1 Calbindin 1, 28 kDa
AKR1B10 Aldo-keto reductase family 1
HIST1H2BK Histone cluster 1, H2bk
HIST1H1B Histone cluster 1, H1b
FST Follistatin
STC2 Stanniocalcin 2
RNU4-1 RNA, U4 small nuclear 1
HSPA6 Heat shock 70 kDa protein 6 (HSP70B')
RGS2 Regulator of G-protein signaling 2, 24 kDa2.9. RNA and microarray processing
Total RNA was extracted from HaCaT cells using a Trizol reagent
(Invitrogen). RNA integrity was checked on an Agilent Bioanalyser
2100 (Agilent Technologies), and RNA samples with N9.0 RIN value
were used in the experiments. A NanoDrop ND-1000was used to deter-
mine RNA concentration. Global expression pattern was analyzed on
Affymetrix GeneChip Rat Gene 1.0 ST arrays. An AmbionWT Expression
Kit (Life Technologies) and a GeneChip WT Terminal Labeling and Con-
trol Kit (Affymetrix) were used for amplifying and labeling 250 ng of
total RNA samples. Samples were hybridized at 45 °C for 16 h and
then the standardwashing protocol was performed using an Affymetrix
GeneChip Fluidics Station 450, and the arrays were scanned on a
GeneChip Scanner 7G (Affymetrix). RNA labeling and hybridization
was processed by UD-GenoMed Medical Genomic Technologies Ltd.
(Debrecen, Hungary).
2.10. Microarray data analysis
Microarray data were analyzed by GeneSpring 12 GX software
(Agilent BioTechnologies). Affymetrix CEL ﬁles were normalized with
a Robust Multichip Analysis (RMA) algorithm and median normaliza-
tion. Expressed genes were determined by ﬁltering out the lowest
20th percentile of genes based on raw signal intensity. Then genes
which did not show at least 1.7-fold change difference from themedian,
were also ﬁltered out as non-changing genes. Statistical analysis was
performed on the list of changing genes using t test. Statistically signif-
icant differencewas considered at p b 0.05 and fold change cut off value
was 1.5. Pathway analysis was performed using Ingenuity software
(Ingenuity Systems). Statistical analysis was performed on the list of
changing genes and the following comparisons were performed using
t-test: control vs. UVA, control vs. siPP1 and siPP1 plus UVA vs. siRNA
(no UVA). Two gene lists were generated and compared in a Venn
diagram and UVA treatment speciﬁc and siRNA treatment speciﬁc
genes were determined. Genes affected by both the PP1-silencing and
UVA radiation treatments are listed separately (Table 1) and present
the cross section in the Venn-diagram (Fig. 3a).
2.11. Mouse skin study
Six-week-old, male Balb/c mice (Charles River) were housed indi-
vidually in stainless steel cages in a controlled atmosphere with a tem-
perature range of 19.0–25.0 °C and a relative humidity of 35.0–75.0%
with a 12/12 h light and dark cycle. Food and water were available ad
libitum. All procedures were authorized by the Institutional EthicsFC absolute p-Value Regulation
1.66 0.028 Up
1.81 0.018 Down
2.79 0.008 Up
2.42 0.002 Down
2.41 0.015 Down
rm 2.83 0.008 Down
1.82 0.033 Up
2.02 0.033 Up
1.76 0.025 Up
1.59 0.030 Up
2.14 0.030 Up
1.66 0.008 Up
1.59 0.030 Up
1.58 0.043 Down
1.51 0.040 Down
1.59 0.004 Up
2.35 0.021 Up
2.45 0.039 Up
2.58 0.046 Up
Fig. 1. Subcellular distribution of PP1 and PP2A in HaCaT cells. (a) HaCaT subcellular frac-
tions (nucleus; cytoskeleton, cytosol) were analyzed by Western blot using antibodies
speciﬁc for PP1cδ and PP1α/γ1 as well as for subcellular fraction-speciﬁc markers such
as histone H1 for nucleus, tubulin for cytoskeleton and GAPDH for cytosol. (b) Protein
phosphatase activity of subcellular fractions was measured using 32P-MLC20 as substrate
in the absence (black columns) or in the presence of 5 nM okadaic acid (OA). Values rep-
resentmean± SEM; n=4, ANOVA ***p b 0.001, **p b 0.01, n.s.: non-signiﬁcant and t-test,
###p b 0.001, ##p b 0.01. (c) Immunoﬂuorescent microscopy of HaCaT cells stained with
anti-PP1cα/γ1 (red), anti-PP1cδ (green) and anti-PP2A (red) speciﬁc antibodies. Nucleus
is stained with DAPI (blue). Scale bar represents 20 μm.
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the guidelines for the care and use of laboratory animals outlined in
the national and European Union ethical regulations. Before UV irradia-
tion and TM treatment [21], the hair ofmicewas removed by a commer-
cially available depilating cream (Veet, Reckitt Benckiser) and the
depilated areas were washed and dried immediately. 24 h after hair re-
moval, dorsal regions of the skin were randomly selected (for vehicle
and for PP1 inhibitor treatment) and labeled. Mice were divided into
two groups (control (no radiation) and UVA-irradiated group) of 9 ani-
mals each. The selected areas were topically treated either with 50 μg
vehicle (hydrophylic anionic cream) or with tautomycin (1 μM ﬁnal
concentration in vehicle) 1 h before UVA irradiation with 3.54 J/cm2.
For UVA exposure, the cages were placed in an irradiation setup
equipped with Philips TL-20 W/12 lamps (Philips, Eindhoven, the
Netherlands) emitted at wavelengths of 315–400 nm and the peak
emission was 365 nm. The intensity of UVA rays was measured by a
UVA ray meter (UVX Radiometer, Saint Gabriel, California, USA) just
before irradiation. The cumulative UVA dose was 531 J/cm2 given ﬁve-
times for 30 min. Animals were killed by cervical dislocation, then the
skin was excised and the subcutaneous fat removed with a scalpel
blade. Tissue samples were frozen in liquid N2 at the time of harvest,
stored at−80 °C and homogenized as described [20]. Protein concen-
tration was determined by BCA assay.
2.12. Histologic image analysis
Digital image information from the H&E-stained sections was
analyzed and the depth of randomly selected areas (n = 10 in each
group for each treatment) of epidermis and total skin was measured
by Image J 1.41 image-analysis software (Wayne Rasband, National
Institutes of Health, Washington, DC, USA).
2.13. Statistical analysis
Normalized data were analyzed by t-test (for two groups) or by
analysis of variance (ANOVA, for N2 groups). Parametric statistical
tests were used if the assumptions of such tests were met. All normal-
ized variables used in statistical analyses were found to be normally
distributed. Tests were conducted using GraphPad for Windows. All
data presented in this work represent mean ± SEM.
3. Results
3.1. Distribution of protein phosphatase-1 catalytic subunit isoforms in
human keratinocytes
As a ﬁrst approach, we studied the subcellular localization of PP1cα,
PP1cγ1, PP1cδ isoforms and PP2A to determine the expression level and
the possible isoform-speciﬁc functions of PP1 and PP2A in keratinocytes.
Subcellular fractions of human keratinocytes (HaCaT) were prepared
using the method reported previously [19] and the purity of nuclear,
cytoskeletal and cytosolic fractions was checked by identiﬁcation of
subcellular fraction-speciﬁc proteins such as histone, tubulin and
GAPDH (Fig. 1a.). As shown on Fig. 1a, PP1cδ was identiﬁed in all
fractions, whereas PP1cα and PP1cγ1 isoforms and PP2Awere predom-
inant in the cytoskeleton and cytosol, while they exhibited lower inten-
sity signals in the nuclear fraction. The abundance of these isoformswas
similar in the cytosolic and in the cytoskeletal fraction. Phosphatase ac-
tivity in the HaCaT subcellular fractions was assayed using a 32P-labeled
myosin light chain of 20 kDa (32P-MLC20) as substrate (Fig. 1b), which
is known to be dephosphorylated by PP1 and PP2A in cell lysates. The
highest protein phosphatase activity could bemeasured in the cytosolic
fraction compared to that in the nuclear and cytoskeletal fractions. It
has already been shown that in diluted cell lysates treatment with
5 nM okadaic acid (OA) inhibits the activity of protein phosphatase 2A
(PP2A) enzymes, but does not inﬂuence PP1 [22]. We considered that
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equalswith the PP1 activity in these fractions. Our data suggest that 50%
of total phosphatase activity is related to PP2A, in both the nuclear and
cytosolic fractions. In contrast, in the cytoskeletal fraction PP1 seemed
to be the dominant form representing ~80% of the phosphatase activity.
We also examined the distribution of PP1 isoforms in HaCaT cells by
ﬂuorescent microscopy (Fig. 1c). These data conﬁrmed that PP1cδ was
localized to both the nucleus and the cytoplasm, whereas PP1cα/γ1
was distributed throughout the cytoplasm but only speckle-like stain-
ing was detectable in the nucleus. The nucleus of the cells was stained
by DAPI (Fig. 1c, middle) and the merged images (Fig. 1c, right panel)
also conﬁrmed the localization pattern of PP1c isoforms suggested
above. The PP2A enzyme exhibited intensive staining throughout the
cell.
3.2. Effect of UVA radiation on the phosphatase activity and survival of
HaCaT cells
To investigate the effect of UV irradiation on the activity of protein
phosphatases and on the viability of keratinocytes, HaCaT cells were ex-
posed to different doses of UV radiation: 1, 5, 10, 15, 20 J/cm2 for UVA
and 0.025, 0.1, 0.05, 1 and 2 J/cm2 for UVB. After UV irradiation the
cells were incubated for 24 h then cell survival was assessed by MTT
assay (Fig. 2a). Phosphatase activity of the lysates (Fig. 2b) was deter-
mined immediately after UVA irradiation with 32P-MLC20 substrate in
order to select an effective UV dose with respect to cell survival and
phosphatase activity. The survival of HaCaT cells decreased in a dose-
dependent manner as a result of exposure to UVA or UVB (Fig. 2a).
UVB irradiation had no signiﬁcant effect on the phosphatase activity of
HaCaT cells, whereas UVA suppressed phosphatase activity in a dose-
dependent manner (Fig. 2b). Based on the above results we selected
the 10 J/cm2 dose of UVA irradiation for our further experiments. To
determine the role of PP1 in UVA-induced effects, PP1c was silenced
by using panPP1c small interfering (si)RNA (siRNA). Forty-eight hours
after siRNA transfection HaCaT cell lysates were prepared to assess the
levels of PP1cδ and PP1cα/γ byWestern blot analysis (Fig. 2c–d). PP1 si-
lencing decreased the expression of PP1α/γ (Fig. 2c) and PP1cδ (Fig. 2d)
by 40% and 60%, respectively. UVA irradiation did not affect PP1cδ level.
Both PP1 silencing and UVA radiation decreased the phosphatase activ-
ity by 25% and 31%, respectively. When PP1 silencing was combined
with UVA radiation, the phosphatase activity decreased further, al-
though no additivity of the individual effects was observed (Fig. 2e).
We assessed also the type speciﬁcity of phosphatase inhibition by TM,
considered as a speciﬁc inhibitor for PP1 [22], and by UVA irradiation
in HaCaT cells. We used recombinant inhibitor-2 [23] to inhibit PP1
speciﬁcally in cell lysate thereby determining the distribution of PP1
and PP2A activities. In the untreated control cell lysate inhibitor-2
(I-2) suppressed the phosphatase activity by ~60%: the remaining phos-
phatase activity is assumed as I-2 insensitive PP2A. Treatment of HaCaT
cells by TM and UVA irradiation, or when the treatments were com-
bined, resulted in 30%, 20% or 22% inhibition of phosphatase activity in
the lysates, respectively. However, the I-2 insensitive (PP2A) activity
of the lysatewas not inﬂuenced by these treatments. These data suggest
that TM treatment or UVA irradiation exerts a PP1 speciﬁc inhibitory
effect in HaCaT cells. The survival of HaCaT cells was measured with
an MTT assay (Fig. 2g). Silencing of PP1 caused an approximately
25–30% decrease in cell survival, while UVA radiation caused even
more pronounced cell death (75%). PP1 silencing combined with UVA
radiation did not further decrease survival compared to that of UVA ra-
diation alone. To provide further data about the extent of apoptosis of
HaCaT and primary human keratinocytes the concentration of PARP
and cleaved PARP was measured by Western blot analysis. Cleavage of
PARP by caspase-3 is considered as an indication of apoptosis [24],
therefore a decrease of the amount of full length PARP and a parallel
appearance of the cleaved fragment upon TM treatment or UVA irra-
diation suggest the occurrence of apoptotic cell death of HaCaT cells(Fig. 2h). TM treatment caused partial degradation of PARP while
UVA irradiation with or without TM pretreatment resulted in a total
loss of PARP and an increased level of cleaved PARP in both HaCaT
and NHEK cell lines.
3.3. Expression analysis of genes in UVA-irradiated keratinocytes: the effect
of PP1 silencing
To examine the role of PP1 silencing alone or in combination with
UVA radiation microarray analysis of gene expression was carried out
in control and PP1c-silenced HaCaT cells with or without UVA irradia-
tion (10 J/cm2). The alterations of gene expression were analyzed by
an Afﬁmetrix program and the cut-off limit was set to 1.5-fold change.
Maximum variation was 2.9- and 4.1-fold compared to control, for
downregulated and upregulated genes, respectively. We performed
hierarchical cluster analysis on all differentially expressed genes using
average linkage with Pearson's dissimilarity and the number of induced
and repressed geneswere presented in a heatmap (Fig. 3a). UVA irradi-
ation decreased the expression level of more than 80% of the genes
(Table S1) while PP1 silencing increased the expression level of about
75% of the genes (Table S2). Since our major focus was to identify the
role of PP1 in UVA-irradiated cells, the expression of genes in both
PP1-silenced and UVA-irradiated HaCaT cells was further analyzed
(Table 1). According to the Venn-diagram (Fig. 3a), 19 genes were
affected by both treatments (Table 1): the expression of each PP1c
isoform (α, β/δ and γ) was dramatically downregulated inferring the
successful silencing of these genes. We also conducted Gene Ontology
(GO) category enrichment analysis to determine themolecular function
of GO terms (Fig. 3b). GO analysis indicated that hair, skin and embryon-
ic development were differentially regulated by siPP1/UVA radiation
treatment. In addition, themajority of these genes play a role in speciﬁc
molecular and cellular functions such as cellular development, molecu-
lar transport and cell signaling. Astonishingly, 75% of these genes are
strongly related to diseases and disorders such as cancer development,
dermatological diseases and conditions as well as genetic disorders.
These ﬁndings were also supported by the network analysis of the
differentially expressed genes (Table S3). These data further support
our hypothesis that PP1 plays a crucial role in the maintenance of nor-
mal dermal functions and is a potentially important modulator of the
epidermal barrier.
3.4. Role of PP1c in the regulation of keratin 1, keratin 10, S100A8 and
histone 1b expression in UVA-irradiated HaCaT cells
Microarray analysis of siPP1c/UVA-irradiatedHaCaT cells indicated a
change in the expression of genes coding for keratin 1 (KRT1) and ker-
atin 10 (KRT10), S100A8 as well as histone 1b comparing to the control
groups. In accordance with these data when HaCaT cells were silenced
for PP1c, or UVA-irradiated, the protein levels of KRT1 and KRT10
were increased (Fig. 4a–b, respectively), and a slight cumulative effect
of PP1c silencing and UVA irradiation was also apparent. No signiﬁcant
change of S100A8 protein level was detected (Fig. 4c) in PP1c-silenced
cells, whereas it was elevated upon UVA irradiation. In contrast, histone
1b protein level was decreased both by PP1c silencing and UVA irradia-
tion but these individual effects were not additive. The human HaCaT
cell line displays a transformed phenotype in vitro and remains
non-tumorigenic [25]. We also intend to test our hypothesis on
NHEK cells that are resistant to transformation when grown under
normal conditions in vitro and retainmany physiological characteris-
tics observed in vivo [26]. Both cell lines provided parallel lines of
evidence about the effect of UVA irradiation and PP1 inhibition on
apoptosis (Fig. 2h) as well as on KRT1, KRT10, S100A8 and histone
1b expression (Fig. 4 a–e). KRT1 and 10 protein expression levels
were increased upon PP1 inhibition and UVA irradiation but S100A8
did not present a notable change after TM treatment. Histone 1b
expression levels were mostly affected by UVA irradiation but the
Fig. 2. Effect of PP1 silencing and UV irradiation on the viability and on the protein phosphatase activity of HaCaT cells. (a) Cells were irradiated by different UVA (1–20 J/cm2)
and UVB (0.0025–2 J/cm2) doses. MTT assays were carried out to assess cell viability of HaCaT cells before (control) and after UVA irradiation. The optical density value of the
control was taken as 100%. (b) HaCaT cells were exposed to the indicated doses of UVA or UVB radiation, and then the phosphatase activity was assayed with a 32P-MLC20
substrate. Phosphatase activity of non-irradiated cells was taken as 100%. (c–f) HaCaT cells were transfected with non-target (control) or PP1-speciﬁc siRNA (siPP1), or ex-
posed to 10 J/cm2 of UVA radiation (UVA), or a combination of these treatments was applied. Expression levels of PP1cα/γ (c) and PP1cδ (d) was determined by Western
blot analysis. (e) Phosphatase activity of the lysates was assayed and values of the non-target siRNA transfected cells without UVA irradiation was taken as 100%.
(f) Phosphatase activity of the HaCaT cells treated with 1 μM of tautomycin (TM) with or without 10 J/cm2 UVA irradiation was assayed. Activities were measured in the ab-
sence (black bars) and the presence (white bars) of 2 μM of inhibitor-2 (I-2). (g) Effect of PP1 silencing and UVA radiation on HaCaT cell viability was quantiﬁed by MTT assay.
The optical density of the control was regarded as 100%. (h) Both TM-treatment and UVA irradiation induce the apoptosis of NHEK and HaCaT cells assayed by Western blot
analysis using PARP and cleaved PARP speciﬁc antibodies as well as actin as loading control. Means ± SEM (n = 4), student t-test *p b 0.05, **p b 0.01, ***p b 0.001, n.s.:
non-signiﬁcant.
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tone 1b expression in NHEK cells. These results have also been con-
ﬁrmed by immunoﬂuorescent staining: a decreased level of PP1 was
detected after PP1c silencing and an increased level of KRT1 was
observed in PP1-silenced and UVA-irradiated HaCaT cells (Fig. 4f). Notonly the expression, but the cellular distribution of KRT1 (green) has
changed too. Due to the results of UVA irradiation or/and siPP1c
treatment, the diffuse localization of KRT1 was taken over by a strong
perinuclear localization. PP1c staining (red) was substantially de-
creased by PP1 silencing.
Fig. 3.Microarray analysis of PP1-silenced and UV-irradiated HaCaT cells. (a) Venn diagram demonstrating the relationship between genes differentially regulated after PP1 silencing
(siPP1) and UVA irradiation in HaCaT cells. The numbers inside the circles represent the number of genes differentially regulated between the two groups. The heat map represents
the hierarchical clustering analysis of the differentially expressed genes for comparing the changes in keratinocytes followed by PP1 silencing, UVA radiation and the combined treatment
as indicated. The color code for the signal strength is shown in the box at the bottom of each individual column; induced genes are highlighted in red, and repressed genes in blue color.
(b) Gene ontology analysis of genes related to UVA radiation and PP1 silencing.
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Fig. 4. Effect of PP1 silencing, PP1 inhibition and UVA radiation on the protein expression of keratin 1, keratin 10, S100A8 and histone 1b of NHEK andHaCaT cells. (a–d) Control and PP1c-
silenced (siPP1) HaCaT cells were irradiated by a 10 J/cm2 UVA dose and the protein expression of keratin 1 (KRT1) (a), keratin 10 (KRT10) (b), S100A8 (c) and histone 1b (d) weremea-
sured by Western blot analysis and the bands were subjected to densitometry and normalized to tubulin as internal control. Means ± SEM (n= 3), student t-test *p b 0.05, **p b 0.01.
(e) Control and TM-treated NHEK cells were irradiated with UVA and KRT1, KRT10, S100A8 and histone 1b protein levels were assayed byWestern blot analysis using actin as internal
control. (f) Immunoﬂuorescent staining of keratin 1 (KRT1, green, left panels) and PP1cδ (PP1, red, middle panel) in HaCaT cells. Merged images (right panel) are also shown. Scale
bar = 20 μm.
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scariﬁcation of mouse skin
We carried out animal experiments treating the skins of Balb/c mice
with tautomycin (TM), a PP1-speciﬁc inhibitor, and UVA irradiation, or
the treatments were combined (TM followed by UVA irradiation).Analysis of skin extracts for protein expression levels of KRT1/10
(Fig. 5a–b, respectively), S100A8 (Fig. 5c) and histone 1b (Fig. 5d)
showed similar features to those presented for PP1c-silenced and
UVA-irradiated HaCaT cells with subtle differences. KRT1/10 was in-
creased, while histone 1b was decreased by both TM treatments and
UVA irradiation or when these challenges were combined. These results
Fig. 5. Inﬂuence of PP1 inhibition and UVA radiation on keratin 1/10, S100A8 and histone 1b expression and on the thickness of murine dorsal skin. (a–g) The dorsal skin of mice was
marked down the center to give a non-irradiated and a UVA-irradiated treatment group (9 mice each), all with vehicle and TM-treated areas. Western blot analysis of skin biopsies
identiﬁed changes in the protein expression level of keratin 1 or 10 (KRT1 or 10) (a and b), S100A8 (c) and histone 1b (His1b) (d) which was quantiﬁed by densitometry normalized
to the density of tubulin as internal control. (e) Immunohistochemical staining of mouse skin with or without UVA irradiation (no radiation), and with (TM) or without TM treatment
(veh: vehicle) for keratin 1, 10 (KRT1, 10), histone 1b and S100A8. Bottompanel: histologic appearance ofmouse skinwith H&E staining. Scale bar= 20 μm.Means± SEM (n=9), paired
t-test *p b 0.05, **p b 0.01, ***p b 0.001.
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level of KRT1, KRT10 and a slight increase in S100A8 expressionwas de-
tectable in the epidermal part of TM-treated and UV-irradiated mouse
skin, and a signiﬁcant decrease could be observed in the number of im-
munoreactive nucleus stained by histone 1b (Fig. 5e). Signiﬁcant chang-
es in the color and the pigmentation of the skin of Balb/c mice were
observed as a result of TM treatment and UV radiation by histologic
(Fig. 5e bottom panel) and macroscopic appearance of the mouse skin.
Severe scariﬁcation was observed as the results of treatment with TM
which was even more apparent following UVA radiation (data are not
shown). H&E-stained mouse skin exhibited a signiﬁcant (1.5-fold)
and a marginal (1.2-fold) increase in the thickness of the viable epi-
dermis of TM-treated and UVA-irradiated skin sections, respectively
(Fig. 1Sa–b). Epidermis in the UVA-exposed TM-treated samples was
thicker than either in the unirradiated control, or inUVA-irradiated sites
referring to a severe epidermal hyperplasia. Prominent deposition of
pigments was observed in UVA-irradiated sections. No signiﬁcant
change in the total thickness of mouse skin was observed (Fig. S1b).
4. Discussion
It is well established that phosphorylation and dephosphorylation of
proteins are important regulatory events in the signaling pathways of
keratinocytes under normal and pathological conditions [7,27]. It has
also been demonstrated that the phospho-Ser/Thr-speciﬁc protein
phosphatases are essential targets in these signaling pathways since
they are involved in the mediation of the phosphorylation level of
many proteins. In mammalian cells three major phosphatase types,
PP1, PP2A and PP2B, are thought to be responsible for the dephosphor-
ylation of more than 90% of the phospho-Ser/Thr residues. These
phosphatase types are present in keratinocytes and the roles of PP2A
and PP2B have been characterized in controlling differentiation, devel-
opment, barrier functions and apoptosis of these cells. It appears that
PP2A may inﬂuence UV irradiation-induced apoptosis of HaCaT cells
[28,29] as well as epidermal barrier formation during development
[30] via regulating the activity and phosphorylation level of Akt kinase
as well as MAPK family enzymes. It is suggested that PP2B (calcineurin)
is required for the normal differentiation and survival of epidermal cells.
PP1 dephosphorylates the retinoblastoma protein [31]; however, other
aspects of PP1 functions in physiological or pathological signaling path-
ways of keratinocytes have not yet been investigated in detail. In this
study we characterized the subcellular distribution of PP1 and PP2A ac-
tivities, and the localization of PP1c isoforms in HaCaT cells. Differential
localization of PP1c isoforms in HeLa cells in nuclear fractions during
mitosis has already been reported [32]. We show here the presence of
all isoforms (PP1cα, PP1cγ and PP1cδ) in HaCaT cells, however regard-
ing subcellular distribution they are all abundant in the cytosolic and
cytoskeletal fractions, but PP1cδ appears to be the major isoform in the
nucleus. These data are also consistent with the conclusions that PP1 iso-
forms are targeted to distinct subcellular compartments permitting
unique and independent roles in keratinocytes.Moreover, we provide ev-
idence here that PP1 enzymes play an important role in the maintenance
of the homeostasis of keratinocytes. This conclusion is supported by the
following experimental results: (i) deletion of PP1c is accompanied with
decreased cell viability; (ii) cell death induced by physiologically relevant
UVA irradiation of HaCaT cells was accompanied by inactivation of PP1
and (iii) both PP1 inhibition and UVA irradiation contribute to the patho-
logical alterations ofmouse skin during separate or combined treatments.
Previous studies have demonstrated contradictive results about the
effect of 10–16 J/cm2 UVA radiation on cell viability of keratinocytes.
Neither cell viability nor DNA synthesis was affected, only the protein
synthesis of the cells were modulated in human cultured keratinocytes
[33], while cell viability of HaCaT cells decreased to 41% upon UVA irra-
diation [34]. Our data suggest that doses higher than the normal daily
dose of UVA (10–18 J/cm2) [35] have amore profound effect on the sur-
vival (5–25%) of HaCaT cells than that of UVB radiation (~50% survival).Another surprising distinction between these treatments is that UVA,
but not UVB irradiation has an effect on protein phosphatase activity
and doses higher than 10 J/cm2 caused an almost 90% reduction of the
activity. The phosphatase assay applied here measures the sum of PP1
and PP2A activities, however, assays in the presence of I-2, a speciﬁc in-
hibitor of PP1, have proved that PP1 is inactivated predominantly by
UVA irradiation. These results are in contrast to recently published
data implying that PP2A may be profoundly activated upon UV irradia-
tion [29] when the phosphatase activity is determined using a synthe-
sized phosphopeptide substrate. The reasons for this discrepancy is
not known, however it should be noted that the UV light source and
the doses applied (70 kJ/m2 and 10 J/cm2 UVA) are quite different in
the reported study [29] and in our present work. UVA irradiation is as-
sumed to be coupled with generation of reactive oxygen species (ROS)
in keratinocytes [36]. It has been shown that ROS could induce inactiva-
tion of PP1 and PP2A by oxidizing cysteinyl residues and the metal
ion(s) at the catalytic centers of PP1c and PP2Ac during cellular senes-
cence of diploid ﬁbroblasts [37]. These data support the hypothesis
that a similar inactivation of PP1 (and PP2A) occurs during UVA irradi-
ation of HaCaT cells which is accompanied with UVA-induced cell
death. Our ﬁnding that the decreased phosphatase activity in siPP1c
cells reduced cell viability further supports the vital role of PP1 in
HaCaT cells as well as in human primary keratinocytes.
Using a microarray approach we explored the possible role of
PP1 enzymes in the regulation of gene expression in human UVA-
irradiated keratinocytes. Thereby, we observed the regulation of genes
implicated in gene expression, free radical scavenging and carbohydrate
metabolism. A modulated transcriptional response was also observed
for some genes involved in the regulation of cell cycle, DNA replication,
recombination and repair, cell morphology, assembly and organization
of the cytoskeletonmainly related to intermediateﬁlament components
such as keratins and tumor marker S100A8 as well as histone 1b.
The physiological system development and function analysis showed
the highest number of affected genes in hair and skin development
and function, in tissue development, and genes related to cancer and
dermatological diseases and conditions. Expression proﬁling of human
keratinocytes in response to UVA has already been demonstrated [38]
but our study is the ﬁrst to reveal the effect of PP1 silencing on gene ex-
pression under resting conditions and following UVA radiation. Nine-
teen genes were identiﬁed as being under the control of PP1 after UVA
irradiation and all of them are known to play a crucial role in the normal
development of the skin by regulating cytoskeletal elements, gene ex-
pression and protein folding and their malfunctions being associated
with malignant transformation.
In order to verify data obtained by hybridization arrays, we con-
ﬁrmed the results for the expression of four out of the 19 genes by
semi-quantitative Western blot analysis. The expression of keratin 1
and 10 intermediate ﬁlament proteins was increased in UVA-exposed
and PP1-silenced HaCaT cells. In addition, the distribution and localiza-
tion of keratinswere also altered reminiscent of the changes observed in
primary hepatocytes treated with microcystin-LR, a potent inhibitor of
both PP1 and PP2A [39]. Consistent with the above data it is reasonable
to assume that suppression of the phosphatase activity by PP1 silencing
or by UVA irradiation has an effect on intermediate ﬁlament reorga-
nization similar to that caused by the phosphatase inhibitory toxin
microcystin-LR. Keratins serve an important role in epithelial cell
protection by the formation of proteinaceous structural framework,
inmotility as well as inmembrane trafﬁcking. Keratin 1/10 overexpres-
sion is increased in skin cancers and is used as a diagnostic tumormark-
er [40]. Our data prove that the gene and protein expression of keratin
1/10 is upregulated and keratins were differentially localized after
UVA irradiation and PP1 silencing indicating an essential role of PP1
enzymes in the maintenance of cytoskeletal integrity. Conversely,
the decrease in PP1 activity is involved in the rearrangement of the
cytoskeleton possibly contributing to the development of pathological
conditions or even to skin cancer. S100A8 calcium binding protein
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gether with keratin 1/10 proteins are upregulated in prostate, gastric
and myoepithelial cancers [41]. Oppositely, histone 1b protein was
found to be downregulated by PP1 silencing and UVA radiation, suggest-
ing marked changes in chromatin structure, including a global reduction
in nucleosome spacing, local reduction in chromatin compaction and
changes in themodiﬁcation of core histones.Moreover, histoneH1partic-
ipates in the regulation of speciﬁc genes that are essential for survival [42].
Although histone 1 (H1) protein may have differential effects in various
cell types, its overexpression was found to delay cell cycle progression
[43] and to act as a general repressor of transcription [44].
The minimal erythemal dose (MED) of UVA has already been deter-
mined on human back skin to be 36.4 J/cm2 [45]. In this study a total
cumulative dose of 531 J/cm2 given in non-erythemogenic 0.5 MED
fractions was shown to elicit erythema response and solar damage to
the skin. Applying these parameters, to investigate the long-term,
cumulative effect of UVA mouse skin was irradiated with a total dose
of 531 J/cm2 in the presence or absence of the PP1 inhibitor tautomycin
(TM). Instead of inﬂammatory symptoms, we observed increased scar-
iﬁcation of the skin as the results of treatmentwith TM,whichwasmore
manifested following UVA radiation with a severe pruritogenic effect as
indicated by scratchmarks. This is in linewith previousﬁndings that cu-
mulative UVA exposure had no inﬂammatory induction and inﬂuence
on the mast cell number, but it caused pigmentation, while tumor in-
duction even at the highest UVA dose could not be determined due to
the extensive scariﬁcation that occurred [46]. The UVA-induced thick-
ening of the epidermis has already been described [45]. We also found
that PP1 inhibition by TM similar to UVA irradiation, or a combination
of TM and UVA, resulted in epidermal hyperplasia. In addition, similar
to our ﬁndings in HaCaT keratinocytes we have also observed increased
protein levels of keratin 1/10 and S100A8 as well as the decreased pro-
tein level of histone 1b in TM-treated UVA-irradiated mouse skin.
In summary, our data imply that PP1 enzymes, besides inﬂuencing
cytoskeletal and cytosolic processes, may have important roles in the
regulation of gene expression in which presumably the PP1cδ isoform
is involved as it is predominant in the nucleus of these cells. Moreover,
PP1 appears to have important functions in the maintenance of normal
homeostasis of keratinocytes since its silencing decreases viability and
PP1 inhibition is accompanied with a UVA irradiation-induced decrease
of survival of HaCaT cells as well as pathological skin alterations. These
data suggest that PP1 is involved in the regulation of important physio-
logical responses of keratinocytes speciﬁcally to UVA irradiation and
dissecting the roles of PP1 in these signaling networks may initiate the
development of novel strategies for prevention and treatment of UV-
related pathologies.
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